ITGAM and neoplasm: A decreased neutrophil-to-lymphocyte-ratio (NLR; Ly6G + CD11b + F4/80− to CD8+) in combo-treated mice compared to Ganetespib treated mice therefore reflects the conversion of the tumor microenvironment into a more immunoactivated state (Fig. 4I).